glp 1 pharmacokinetics GLP-1 RAs parameters GLP-1 Receptor Agonists in Solid
Description
With its higher comparative efficacy, Mounjaro launched at just the right time: public awareness of GLP-1s was increasing and demand skyrocketed
Pfizer is developing a long-acting GLP-1 drug that could compete directly with Eli Lilly's Mounjaro and Zepbound when it reaches the Canadian market.
135 million obese Indians
Pfizer has made obesity, and the broader metabolic space, one of the core fixtures of its pipeline for the next decade
Learn how to manage it during your weight loss journey.
